US Approves Tezild For Young Children
The United States has approved the use of the drug Tezild for children starting from one year of age. Previously, the medication was only permitted for children aged eight and older in the European Union and the United States.
Topics
Developing
- 890d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 890d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 890d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 890d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
Monte Carlo Doualiya
“the US approval of the drug Tezild starting from one year of age opens an important new page in the care of young children suffering from Type 1 diabetes.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade